Awards

Listed in Stanford University’s "World's Top 2% Scientists" (2024)

Included in the prestigious global ranking based on standardized citation metrics compiled by Elsevier through Scopus data. Ranked #144 out of 14,394 in the subfield of Legal & Forensic Medicine under the main field Clinical Medicine, based on a composite citation score.

(Source: Elsevier & ICSR Lab, Stanford University Database of Top Scientists)

• Highly Cited Research Recognition (2021–2022)
  Journal of Medical Virology
  – For articles on Omicron and Delta variant comparative modeling.
  – Acknowledged for being among the most read and cited publications of the journal.

AD Scientific Index 2025

Dr. Suresh Kumar is a leading academic and researcher in the fields of Bioinformatics, Genomics, and Infectious Diseases, currently serving at Management & Science University (MSU), Malaysia. His research excellence and scientific contributions have earned him top rankings in the AD Scientific Index 2025, where he holds the #1 position in both Natural Sciences and Molecular Biology & Genetics at MSU.

In the domain of Natural Sciences, Dr. Kumar is ranked first among 1,026 scientists at MSU and is positioned in the top 0.1%, reflecting his exceptional impact within the institution. In Molecular Biology & Genetics, he ranks first among 11 peers, placing him in the top 9.09%. His work has gained recognition at the national and international levels, with rankings that include:

• 1,696 scientists in Malaysia
  
  

• 84,175 scientists across Asia
  
  

• 309,746 scientists globally in Natural Sciences
  and
  
  

• 350 scientists in Malaysia
  
  

• 12,899 in Asia
  
  

• 58,423 worldwide in Molecular Biology & Genetics
  
  

Dr. Kumar’s interdisciplinary approach bridges computational biology and applied medical research, with a special focus on COVID-19, antibiotic resistance, and genomic surveillance of emerging pathogens. His extensive body of work and academic leadership have significantly advanced molecular-level understanding of infectious diseases, making him a prominent contributor to the global scientific community.